Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaoundé, Cameroon, in the Post-Vaccine Era.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
05 09 2019
Historique:
entrez: 11 9 2019
pubmed: 11 9 2019
medline: 29 9 2020
Statut: ppublish

Résumé

Meningitis is endemic to regions of Cameroon outside the meningitis belt including the capital city, Yaoundé. Through surveillance, we studied the etiology and molecular epidemiology of pediatric bacterial meningitis in Yaoundé from 2010 to 2016. Lumbar puncture was performed on 5958 suspected meningitis cases; 765 specimens were further tested by culture, latex agglutination, and/or polymerase chain reaction (PCR). Serotyping/grouping, antimicrobial susceptibility testing, and/or whole genome sequencing were performed where applicable. The leading pathogens detected among the 126 confirmed cases were Streptococcus pneumoniae (93 [73.8%]), Haemophilus influenzae (18 [14.3%]), and Neisseria meningitidis (15 [11.9%]). We identified more vaccine serotypes (19 [61%]) than nonvaccine serotypes (12 [39%]); however, in the latter years non-pneumococcal conjugate vaccine serotypes were more common. Whole genome data on 29 S. pneumoniae isolates identified related strains (<30 single-nucleotide polymorphism difference). All but 1 of the genomes harbored a resistance genotype to at least 1 antibiotic, and vaccine serotypes harbored more resistance genes than nonvaccine serotypes (P < .05). Of 9 cases of H. influenzae, 8 were type b (Hib) and 1 was type f. However, the cases of Hib were either in unvaccinated individuals or children who had not yet received all 3 doses. We were unable to serogroup the N. meningitidis cases by PCR. Streptococcus pneumoniae remains a leading cause of pediatric bacterial meningitis, and nonvaccine serotypes may play a bigger role in disease etiology in the postvaccine era. There is evidence of Hib disease among children in Cameroon, which warrants further investigation.

Sections du résumé

BACKGROUND
Meningitis is endemic to regions of Cameroon outside the meningitis belt including the capital city, Yaoundé. Through surveillance, we studied the etiology and molecular epidemiology of pediatric bacterial meningitis in Yaoundé from 2010 to 2016.
METHODS
Lumbar puncture was performed on 5958 suspected meningitis cases; 765 specimens were further tested by culture, latex agglutination, and/or polymerase chain reaction (PCR). Serotyping/grouping, antimicrobial susceptibility testing, and/or whole genome sequencing were performed where applicable.
RESULTS
The leading pathogens detected among the 126 confirmed cases were Streptococcus pneumoniae (93 [73.8%]), Haemophilus influenzae (18 [14.3%]), and Neisseria meningitidis (15 [11.9%]). We identified more vaccine serotypes (19 [61%]) than nonvaccine serotypes (12 [39%]); however, in the latter years non-pneumococcal conjugate vaccine serotypes were more common. Whole genome data on 29 S. pneumoniae isolates identified related strains (<30 single-nucleotide polymorphism difference). All but 1 of the genomes harbored a resistance genotype to at least 1 antibiotic, and vaccine serotypes harbored more resistance genes than nonvaccine serotypes (P < .05). Of 9 cases of H. influenzae, 8 were type b (Hib) and 1 was type f. However, the cases of Hib were either in unvaccinated individuals or children who had not yet received all 3 doses. We were unable to serogroup the N. meningitidis cases by PCR.
CONCLUSIONS
Streptococcus pneumoniae remains a leading cause of pediatric bacterial meningitis, and nonvaccine serotypes may play a bigger role in disease etiology in the postvaccine era. There is evidence of Hib disease among children in Cameroon, which warrants further investigation.

Identifiants

pubmed: 31505633
pii: 5561334
doi: 10.1093/cid/ciz506
pmc: PMC6761319
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S148-S155

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Philos Trans R Soc Lond B Biol Sci. 2013 Feb 04;368(1614):20120202
pubmed: 23382424
Pediatr Infect Dis J. 2008 Dec;27(12):1047-51
pubmed: 18989240
Hum Vaccin Immunother. 2018;14(12):2955-2956
pubmed: 30060701
Sci Rep. 2017 Aug 15;7(1):8127
pubmed: 28811633
Emerg Infect Dis. 1999 May-Jun;5(3):336-45
pubmed: 10341170
Microb Genom. 2015 Aug 11;1(2):e000027
pubmed: 28348812
Emerg Infect Dis. 2003 Oct;9(10):1351-3
pubmed: 14626225
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Emerg Infect Dis. 2002 Mar;8(3):327-9
pubmed: 11927034
MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1159-62
pubmed: 25503919
Bull Soc Pathol Exot. 2001 Nov;94(4):300-3
pubmed: 11845520
Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S410-5
pubmed: 26553668
PLoS One. 2016 Feb 01;11(2):e0147765
pubmed: 26829233
Emerg Infect Dis. 2011 Nov;17(11):2070-2
pubmed: 22099102
Scand J Infect Dis. 2002;34(5):379-82
pubmed: 12069024
Expert Rev Vaccines. 2009 Jan;8(1):91-102
pubmed: 19093776
Lancet Glob Health. 2016 Mar;4(3):e185-94
pubmed: 26853149
BMC Infect Dis. 2016 Oct 18;16(1):575
pubmed: 27756235
J Clin Microbiol. 2013 Feb;51(2):647-52
pubmed: 23224094
Lancet. 2000 Oct 7;356(9237):1210-1
pubmed: 11072934
Clin Infect Dis. 2019 Apr 24;68(9):1512-1521
pubmed: 30165376
Microb Genom. 2017 Sep 4;3(10):e000131
pubmed: 29177089
MBio. 2016 Jun 07;7(3):
pubmed: 27273824
Lancet Glob Health. 2017 Dec;5(12):e1176-e1177
pubmed: 29128252

Auteurs

Angeline Boula (A)

Centre Mere et Enfant de la Fondation, Yaoundé, Cameroon.

Madikay Senghore (M)

World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, West Africa Partnerships and Strategy, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

Rose Ngoh (R)

Centre Mere et Enfant de la Fondation, Yaoundé, Cameroon.

Flaubert Tassadjo (F)

Centre de Pasteur, Yaoundé.

Marie-Christine Fonkoua (MC)

Centre de Pasteur, Yaoundé.

Ariane Nzouankeu (A)

Centre de Pasteur, Yaoundé.

Mina Kenkela Njiki (MK)

Centre Mere et Enfant de la Fondation, Yaoundé, Cameroon.

Jeanne Musi (J)

Centre de Pasteur, Yaoundé.

Sandrine Bebey (S)

Centre Mere et Enfant de la Fondation, Yaoundé, Cameroon.

Madeline Ngo Baleba (M)

Centre Mere et Enfant de la Fondation, Yaoundé, Cameroon.

Angeline Nkembe (A)

Centre Mere et Enfant de la Fondation, Yaoundé, Cameroon.

Sidonie Médjina (S)

Expanded Programme on Immunization, Yaoundé.

Peter S Ndow (PS)

World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, West Africa Partnerships and Strategy, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

Archibald Worwui (A)

World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, West Africa Partnerships and Strategy, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

Marie Kobela (M)

Expanded Programme on Immunization, Yaoundé.

Marceline Nimpa (M)

WHO Country Office Cameroon, Yaoundé.

Jason M Mwenda (JM)

WHO Regional Office for Africa, Brazzaville, Republic of Congo.

Aboubacar N'diaye (A)

WHO Regional Office for Africa, Brazzaville, Republic of Congo.

Brenda A Kwambana-Adams (BA)

World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, West Africa Partnerships and Strategy, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

Martin Antonio (M)

World Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, West Africa Partnerships and Strategy, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH